Ipca Laboratories, through its wholly owned subsidiary Ipca Laboratories UK has acquired 100% stake in Onyx Research Chemical, holding company of Onyx Scientific. The acquisition brings together two contract manufacturing organization (CMOs) to better serve their customers on a global basis.
Onyx Scientific has been a chemistry solution provider for over a decade and will continue to operate out of the Silverbriar (Sunderland, UK) facility under the Onyx Scientific trade name. Onyx’s capabilities in chemistry services for medicinal, preclinical and phase -I/II programs will dovetail effectively with Ipca’s capabilities in supporting phase II to commercial scale programmes.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.75 |
Dr. Reddys Lab | 1341.60 |
Cipla | 1471.70 |
Lupin | 2168.25 |
Zydus Lifesciences | 972.30 |
View more.. |